Virogen Corporation Receives Manufacturing License Opening Door to Sales in Worldwide Market

MINNEAPOLIS, MN--(Marketwire - August 19, 2008) - Virogen, Inc. (PINKSHEETS: VRGI), the developer and patent holder of a revolutionary vaccine to combat Newcastle disease, a deadly disease that kills chickens worldwide, announced that on July 19, 2008 a manufacturing license was issued for its Innovo Immune Newcastle Vaccine by the Government of Romania, a European Economic Community member country. This certification meets the European Union standard which is recognized by virtually every country in the world.